Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio A Demarco

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Cancer Immunology, Immunotherapy : CII|June 25, 2018
Antibody-dependent cell-mediated cytotoxicity induced by active immunotherapy based on racotumomab in non-small cell lung cancer patientsValeria I Segatori, Héctor A Cuello, Cynthia A Gulino, et al.
The Journal of Biological Chemistry|December 24, 2002
Involvement of a Na+/HCO-3 cotransporter in mouse sperm capacitationIgnacio A Demarco, Felipe Espinosa, Jennifer Edwards, et al.
Translational Lung Cancer Research|October 24, 2025
Combination of racotumomab immunotherapy with programmed death-1 blockade in a preclinical model of non-small cell lung cancerValeria I Segatori, Selene Rojo, Cynthia A Gulino, et al.
Cell|June 26, 2012
DNA sequence-dependent compartmentalization and silencing of chromatin at the nuclear laminaJoseph M Zullo, Ignacio A Demarco, Roger Piqué-Regi, et al.
Cancers|October 14, 2022
Preclinical Efficacy and Toxicology Evaluation of RAC1 Inhibitor 1A-116 in Human Glioblastoma ModelsGeorgina A Cardama, Julian Maggio, Lucas Valdez Capuccino, et al.
Animals : an Open Access Journal From MDPI|August 12, 2023
In Silico and In Vitro Evaluation of Bevacizumab Biosimilar MB02 as an Antitumor Agent in Canine Mammary CarcinomaGeorgina A Cardama, Paula L Bucci, Jesús S Lemos, et al.
Investigational New Drugs|March 14, 2020
Administration of the vasopressin analog desmopressin for the management of bleeding in rectal cancer patients: results of a phase I/II trialSoledad Iseas, Enrique L Roca, Juan M O'Connor, et al.
Springerplus|August 26, 2015
A phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-d-arginine vasopressin) in breast cancer patientsRuth S Weinberg, Marcelo O Grecco, Gimena S Ferro, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cancer Immunology, Immunotherapy : CII|June 25, 2018
Antibody-dependent cell-mediated cytotoxicity induced by active immunotherapy based on racotumomab in non-small cell lung cancer patientsValeria I Segatori, Héctor A Cuello, Cynthia A Gulino, et al.
The Journal of Biological Chemistry|December 24, 2002
Involvement of a Na+/HCO-3 cotransporter in mouse sperm capacitationIgnacio A Demarco, Felipe Espinosa, Jennifer Edwards, et al.
Translational Lung Cancer Research|October 24, 2025
Combination of racotumomab immunotherapy with programmed death-1 blockade in a preclinical model of non-small cell lung cancerValeria I Segatori, Selene Rojo, Cynthia A Gulino, et al.
Cell|June 26, 2012
DNA sequence-dependent compartmentalization and silencing of chromatin at the nuclear laminaJoseph M Zullo, Ignacio A Demarco, Roger Piqué-Regi, et al.
Cancers|October 14, 2022
Preclinical Efficacy and Toxicology Evaluation of RAC1 Inhibitor 1A-116 in Human Glioblastoma ModelsGeorgina A Cardama, Julian Maggio, Lucas Valdez Capuccino, et al.
Animals : an Open Access Journal From MDPI|August 12, 2023
In Silico and In Vitro Evaluation of Bevacizumab Biosimilar MB02 as an Antitumor Agent in Canine Mammary CarcinomaGeorgina A Cardama, Paula L Bucci, Jesús S Lemos, et al.
Investigational New Drugs|March 14, 2020
Administration of the vasopressin analog desmopressin for the management of bleeding in rectal cancer patients: results of a phase I/II trialSoledad Iseas, Enrique L Roca, Juan M O'Connor, et al.
Springerplus|August 26, 2015
A phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-d-arginine vasopressin) in breast cancer patientsRuth S Weinberg, Marcelo O Grecco, Gimena S Ferro, et al.
Pageof 2